These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9194512)

  • 41. Control of sodium excretion in NE-ACTH hypertension: role of pressure natriuresis.
    Woods LL; Mizelle HL; Hall JE
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R894-900. PubMed ID: 2849322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice.
    James ML; Wang H; Venkatraman T; Song P; Lascola CD; Laskowitz DT
    J Neurotrauma; 2010 Jan; 27(1):217-28. PubMed ID: 19803787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
    McMahon EG; Yang PC; Babler MA; Suleymanov OD; Palomo MA; Olins GM; Cook CS
    Am J Hypertens; 1997 Jun; 10(6):671-7. PubMed ID: 9194514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
    Harland D; Brown MJ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central and peripheral effects of the peptide ANF on renal function and blood pressure in hypertensive rats.
    al-Barazanji K; Balment RJ
    J Physiol; 1989 Nov; 418():261-71. PubMed ID: 2533609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide.
    Clemens LE; Almirez RG; Baudouin KA; Mischak RP; Grossbard EB; Protter AA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):67-71. PubMed ID: 9765323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
    Cataliotti A; Chen HH; Schirger JA; Martin FL; Boerrigter G; Costello-Boerrigter LC; James KD; Polowy K; Miller MA; Malkar NB; Bailey KR; Burnett JC
    Circulation; 2008 Oct; 118(17):1729-36. PubMed ID: 18838565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.
    Abraham WT; Lowes BD; Ferguson DA; Odom J; Kim JK; Robertson AD; Bristow MR; Schrier RW
    J Card Fail; 1998 Mar; 4(1):37-44. PubMed ID: 9573502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human brain natriuretic peptide reduces blood pressure in normotensive and acute norepinephrine-induced hypertensive rabbits.
    Clemens LE; Almirez RG; Baudouin KA; Grossbard EB; Protter AA
    Am J Hypertens; 1997 Jun; 10(6):654-61. PubMed ID: 9194512
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.